Isotretinoin Drugs Market Research Report- Forecast To 2027

Isotretinoin Drugs Market Information, by application (severe acne, Neuroblastoma, Cutaneous T-Cell Lymphomas, harlequin ichthyosis, xeroderma pigmentosum, fibrodysplasia ossificans progressiva, Squamous cell skin cancers, and others), by End User (Hospitals, Research laboratories, and others) - Forecast to 2027

ID: MRFR/Pharma/2418-HCR | February 2021 | Region: Global | 73 pages

Isotretinoin Drugs Market Overview 


The isotretinoin drugs market growth is projected at 3.2%, expected to reach USD 1567.1 million for the forecast period. Isotretinoin is a dermatological condition that is caused by inflammation in hair follicles. Hormonal imbalance is a major reason for isotretinoin. Also, isotretinoin is a drug for severe acne. Oily skin, impurities, bacteria, stress, high water and sugar intake can cause isotretinoin. There are plenty of medications variable for acne in the medical industry. However, isotretinoin is a special component that can even treat chronic acne conditions. It can decrease oil production and control acne breakouts.


In many cases, acne can cause high inflammation and scars on the skin. However, thorough isotretinoin drugs all these conditions are preventable. The isotretinoin is over a counter mediation that has high demand in many regions. The developing and developed regions have a high demand for isotretinoin. The rate of population skin problems is high in this region.


Also, the spending on skin medications is high in these areas. All these factors increase the overall demand of the isotretinoin drugs market. As per a medical journal, the cases of isotretinoin are expected to grow more in the next few years. The hormonal problems in individuals are raising the need for isotretinoin drugs. Emerging economies have a high interest in isotretinoin drugs. The prevalence of this condition due to hot weather is a reason for high growth. All these factors will the overall isotretinoin drugs market value immensely.


Covid analysis 


Covid 19 is creating unprecedented changes in industries. In the medical industry, essential treatments have the highest demand. During this pandemic, the isotretinoin drugs market is witnessing a declining trend. Treatment for other essential problems is delayed. Also, the lockdowns and restrictions, patients visiting dermatologists are reducing. Even the supply chain problems delay the isotretinoin drugs delivery. 


The cases of severe acne in hospitals have been considerably low. These factors decline the overall growth of isotretinoin drugs market. During this period, the isotretinoin drugs market is under massive research. More drug developments are expected post covid 19. Innovation, new products, product launches and effective drugs will be available in upcoming years. Also, the investment for the market is rising in this period. The delayed treatments for the isotretinoin conditions will start in 2021. All these factors will create positive market scenarios post covid. 


Market dynamics 



  • Crucial market drivers 


The rising prevalence of skin diseases is a crucial driver for the isotretinoin drugs market. There are acne vulgarised and chronic acne disease is leading to high demand. Urban and unhealthy lifestyles may lead to several skin problems. In developed and developing nations the growth of urbanization is massive.


Due to urbanisation, the work pressure is higher for many individuals. Women are prone to acne conditions. This condition is also prevalent in men. However, the increasing rate of acne conditions in women is raising the demand for isotretinoin drugs. The tremendous demand and interest of the urban population towards skin treatment is another driving factor. The urban cities have high spending on skin treatments. It leads to higher awareness about isotretinoin drugs.


These developments in the market lead to robust development in the isotretinoin drugs pipeline. There are different types of isotretinoin drugs that are available according to the severity of the condition. Rising applications of isotretinoin is another factor increasing demand. It not only control acne breakouts and blisters but also controls inflammation. The texture of the skin is even through these drugs. All these factors will have an exceptional impact on isotretinoin drugs. 



  • Market growth opportunities 


The growth in research and development will lead to isotretinoin drugs opportunities. The research and development investments for the health sector are tremendous for the forecast period. It provides high developments for the dermatology sector. There is a high of the new range of drugs in the market. The research is high due to the funding from the government for this market. From covid 19, the governmental direct investment for the health sector is tremendous. All the field of the health industry is rapidly developing. 


These factors will contribute to the high collaboration dermatology and pharmaceutical market. The launch of new and efficient drugs through this collaboration will bring exceptional growth opportunities. The key players of the isotretinoin drugs market are increasing their product range. Research in the market will lead to high awareness about isotretinoin drugs. The key players in the market are developing Isotretinoin drugs that have fewer side effects. The launch of these drugs is expected to create a wide range of opportunities in the isotretinoin drugs market. 



  • The market restraints 


Side effects of the drugs are a drawback of isotretinoin drugs market. The side effects of the drugs impede the growth rate of the market. Isotretinoin is an effective drug. Severe skin propels are treatable through the drugs. During the treatment process, a few side effects are involved. Dry, skin, dry mouth, rash, itching nose bleeds are prevalent. However, these side effects do not affect the treatment. 


However, many individuals think that their condition is worsening due to the drugs. However, acne drugs come with these common side effects. It regulates hormonal imbalance. These factors will lead to high side effects of the drugs. Also, less awareness about isotretinoin drugs is a restraining factor of the isotretinoin drugs market. In emerging economies have less demand for drugs in the forecast period.  



  • The market challenges 


The stringent governmental policies for isotretinoin drugs are a crucial market challenge. Today, getting new drugs approval has many challenges. Various clinical trials and regulatory policies are included in the process. Lack of infrastructure in emerging economies makes less investment for the isotretinoin drugs market. 


The poor delivery channels to transport the isotretinoin drugs are another factor affecting the isotretinoin drugs market growth. This can lead to poor demand in less developed regions for the market. Further, there are several alternatives for the isotretinoin drugs that can impede isotretinoin drugs market growth. The alternatives of these drugs come with fewer side effects that lead to high growth for these alternatives. 



  • Cumulative growth analysis 


There are therapeutic, formulation and different types of isotretinoin drugs available in the market. All these segments provide exceptional profits in the forecast period. The drug stores and pharmaceuticals have exceptional demand for these isotretinoin drugs.


Isotretinoin drugs market analysis shows a positive growth trend due to these factors. Crucial drivers of the market such as the prevalence of skin issues and high demand due to urbanization will propel the demand. Side effects of these isotretinoin drugs are a restraint of the market. Also, several alternatives in the market can decline the demand of isotretinoin drugs market. However, research and development will lead to high growth opportunities in the isotretinoin drugs market. 



  • Value chain analysis 


North America will hold the highest shares in the isotretinoin drugs market. This region will hold its dominance in the global market with the highest demand. The availability of isotretinoin drugs is higher in the region. Also, the adoption of online pharmacies to supply isotretinoin drugs is rising.


The market has top isotretinoin manufacturers to product new type of drugs. In the forecast period, new developments and expansions are higher in the isotretinoin drugs market. The massive investment of the market will bring new product launches. These medicines also come with fewer side effects. 


Segment overview 


By application 



  • Cell skin cancers 

  • Severe acne 

  • Fibrodysplasia ossificans progressive 

  • Neuroblastoma 

  • Xeroderum pigmentisum 


By end-user 



  • Research laboratories 

  • Hospitals 


By region 



  • Asia pacific 

  • Europe 

  • North America 

  • The Middle East and Africa 


Competitive landscape 


The competition in the isotretinoin drugs market is moderate. There are new product launches and advancements in the overall market. Acquisitions, expansions, mergers, collaborations and partnerships will increase in the market. Research and development will take place in the market. The key players of the market are developing medication that comes with fewer side effects. All these are the key strategies in the competitive landscape.


Regional analysis 


The regional players of the isotretinoin drugs market are Asia Pacific, Europe and North America. North America will have high growth. The key players in US and Canada are investing more in isotretinoin drugs. The awareness about isotretinoin drugs is higher in the forecast period.


The isotretinoin drugs market scenario is favourable for developments. The Asia Pacific is the next largest key player with a high amount of shares. The isotretinoin manufacturers in India are facing tremendous demand in the isotretinoin drugs market. The production of these drugs is rising in the market. Also, emerging nations such as Europe and the Middle East will have higher growth potential.


The isotretinoin drugs market key players are 



  1. Teva pharmaceuticals 

  2. Akron 

  3. SUN PHARMA Company 

  4. DR reddy’s laboratories. Ltd. 

  5. Ranbaxy laboratories 

  6. Hoffman-LA Roche Ltd. 

  7. Mylan 


Recent developments 



  1. The isotretinoin drugs market is expanding in emerging economies. Plenty of isotretinoin drugs facilities are developing in these regions. 



  1. The key players of the market are launching isotretinoin drugs that come with lesser side effects. 


Report overview 



  1. Market overview highlights 

  2. Analysis based upon COVID 19

  3. Explanation upon the Market Dynamics

  4. Value chain analysis

  5. Market segmentation overview

  6. The regional analysis

  7. Competitive landscape analysis

  8. Recent Developments



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 1567.1 Million
  CAGR   3.2% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Akorn, Inc. (US), Dr. Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (US), Ranbaxy Laboratories Inc, a SUN PHARMA company. (India), Teva Pharmaceuticals USA, Inc (US)
  Key Market Opportunities   Technological advancement, and Increasing healthcare spending
  Key Market Drivers

  • Increasing prevalence of skin and genetic disorders \r\n
  • Rising cases of skin cancer


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Research and developments and new product launches are new strategies in the market.

    The key players of the market are Teva pharmaceuticals, Akron, SUN PHARMA Company, DR reddy’s laboratories. Ltd., Ranbaxy laboratories, F. Hoffman-LA Roche Ltd. and Mylan.

    1. Report Prologue

    2. Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    2.3 Market Structure

    2.4. Market Segmentation

    3. Research Methodology

    3.1 Research Process

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    3.5 Forecast Model

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Mega Trends

    4.5 Macroeconomic Indicators

    5. Market Factor analysis

    5.1 Value Chain Analysis

    5.2 Porters Five Forces

    5.3 Demand & Supply: Gap Analysis

    5.4 Pricing Analysis

    5.5 Investment Opportunity Analysis

    5.6 Merger and Acquisition Landscape

    5.7 Upcoming trends

    5.7.1 Market trends

    5.7.2 Technological trends

    5.7.3 Insurance & Regulations

    5.7.4 Others

    6. Global Isotretinoin drugs Market by Application

    6.1 Severe acne

    6.1.1 Nodulocystic acne

    6.1.2 Acne conglobate

    6.1.3 Acne fulminans

    6.1.4 Gram negative folliculitis

    6.1.5 Others

    6.2 Neuroblastoma

    6.2.1 Stage 1

    6.2.2 Stage 2A

    6.2.3 Stage 2B

    6.2.4 Stage 3

    6.2.5 Stage 4

    6.2.6 Stage 4S

    6.2.7 Others

    6.3 Cutaneous T-Cell Lymphomas

    6.3.1 Mycosis fungoides

    6.3.2 Pagetoid reticulosis

    6.3.3 Lymphomatoid papulosis

    6.3.4 Granulomatous slack skin

    6.3.5 Others

    6.4 Harlequin ichthyosis

    6.5 Xeroderma pigmentosum

    6.5.1 Group A

    6.5.2 Group B

    6.5.3 Group C

    6.5.4 Group D

    6.5.6 Others

    6.6 Fibrodysplasia ossificans progressive

    6.7 Squamous cell skin cancers

    6.8 Others

    7. Global Isotretinoin drugs Market by End user

    7.1 Hospitals

    7.2 Research laboratories

    7.3 Others

    8. Global Isotretinoin drugs Market by Region

    8.1 Introduction

    8.2 America

    8.2.1 North America

    8.2.1.1 The US

    8.2.1.2 Canada

    8.2.2 South America

    8.3 Europe

    8.3.1 Western Europe

    8.3.1.1 Germany

    8.3.1.2 France

    8.3.1.3 Italy

    8.3.1.3 Spain

    8.3.1.5 UK

    8.3.1.6 Rest of Western Europe

    8.3.2 Eastern Europe

    8.4 Asia

    8.4.1 China

    8.4.2 India

    8.4.3 Japan

    8.4.4 South Korea

    8.4.5 Rest of Asia

    8.5 Pacific

    8.6 Middle East and Africa

    8.6.1 UAE

    8.6.2 Saudi Arabia

    8.6.3 Egypt

    8.6.4 Rest of Middle East and Africa

    9. Competitive landscape

    10. Company profile

    11 Conclusion

    11.1 Key findings

    9.1.1 From CEO’s viewpoint

    9.1.2 Unmet needs of the market

    11.2 Key companies to watch

    11.3 Prediction of Isotretinoin drugs Market

    12 Appendix